Junbo Zhou

543 total citations
31 papers, 391 citations indexed

About

Junbo Zhou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Junbo Zhou has authored 31 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Junbo Zhou's work include Ubiquitin and proteasome pathways (4 papers), Cancer-related molecular mechanisms research (4 papers) and RNA modifications and cancer (4 papers). Junbo Zhou is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Cancer-related molecular mechanisms research (4 papers) and RNA modifications and cancer (4 papers). Junbo Zhou collaborates with scholars based in China, Mexico and Germany. Junbo Zhou's co-authors include Jian Gong, Guiqin Chen, Jinyun Ye, Fang Cao, Zhili Ding, Yixiang Zhang, Youqin Kong, Yang Zheng, Xu Ding and Xiaomeng Song and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cell Death and Differentiation and Biochemical Pharmacology.

In The Last Decade

Junbo Zhou

30 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junbo Zhou China 13 217 91 74 68 65 31 391
Qian Lin China 13 276 1.3× 78 0.9× 120 1.6× 39 0.6× 87 1.3× 24 554
Zhitong Deng China 12 199 0.9× 77 0.8× 34 0.5× 39 0.6× 25 0.4× 21 349
Nadia Ninfa Albanese Italy 16 284 1.3× 148 1.6× 53 0.7× 62 0.9× 13 0.2× 19 596
Xuan Xie China 12 135 0.6× 45 0.5× 106 1.4× 18 0.3× 35 0.5× 29 466
Su-Jae Lee South Korea 13 314 1.4× 103 1.1× 79 1.1× 189 2.8× 24 0.4× 19 683
Reidun Aesöy Norway 13 272 1.3× 48 0.5× 19 0.3× 106 1.6× 25 0.4× 24 485
Joshua Brown-Clay United States 6 298 1.4× 140 1.5× 106 1.4× 97 1.4× 6 0.1× 7 550
Kazuhisa Minamiguchi Japan 12 145 0.7× 74 0.8× 25 0.3× 40 0.6× 107 1.6× 25 404
Kenichi Iwai Japan 12 217 1.0× 35 0.4× 53 0.7× 71 1.0× 16 0.2× 29 446
Yuwei Zhang China 9 180 0.8× 30 0.3× 68 0.9× 75 1.1× 12 0.2× 30 363

Countries citing papers authored by Junbo Zhou

Since Specialization
Citations

This map shows the geographic impact of Junbo Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junbo Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junbo Zhou more than expected).

Fields of papers citing papers by Junbo Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junbo Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junbo Zhou. The network helps show where Junbo Zhou may publish in the future.

Co-authorship network of co-authors of Junbo Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Junbo Zhou. A scholar is included among the top collaborators of Junbo Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junbo Zhou. Junbo Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yin, Jiale, Guohai Liu, Yu Zhou, et al.. (2025). The WW domain presents a promising target for the development of PCIF1 agonists in the treatment of glioma. npj Precision Oncology. 9(1). 329–329.
2.
Teng, Xu, Yuemei Yang, Zhihong Chen, et al.. (2023). TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEAP1/NRF2 signaling. Journal of Experimental & Clinical Cancer Research. 42(1). 190–190. 24 indexed citations
3.
Liu, Dongliang, et al.. (2023). Mitophagy in ototoxicity. Frontiers in Cellular Neuroscience. 17. 1140916–1140916. 7 indexed citations
4.
Wang, Chao, Zhihong Chen, Xueming Yang, et al.. (2022). Identification of Biomarkers Related to Regulatory T Cell Infiltration in Oral Squamous Cell Carcinoma Based on Integrated Bioinformatics Analysis. SHILAP Revista de lepidopterología. 2 indexed citations
5.
Zhang, Xiaoyang, Yanfeng Yan, Xin Li, et al.. (2022). Dendrobium officinale polysaccharides attenuate uropathogenic Escherichia coli (UPEC)-induced pyroptosis in macrophage cells. Biomedicine & Pharmacotherapy. 151. 113098–113098. 13 indexed citations
6.
Zheng, Yang, Chao Wang, Chundi Wang, et al.. (2022). Regulation of Semaphorin3A in the process of cutaneous wound healing. Cell Death and Differentiation. 29(10). 1941–1954. 12 indexed citations
7.
Wang, Xiaomei, Zhongshan Zhang, Shaoyong Zhang, et al.. (2021). Antiaging compounds from marine organisms. Food Research International. 143. 110313–110313. 16 indexed citations
8.
Song, An, Junbo Zhou, Jinhai Ye, et al.. (2021). Ubiquitin D Promotes Progression of Oral Squamous Cell Carcinoma via NF-Kappa B Signaling. Molecules and Cells. 44(7). 468–480. 14 indexed citations
9.
Zhou, Junbo, Yue Wu, Liquan Yang, et al.. (2021). A novel biphenyl diester derivative, AB38b, inhibits glioblastoma cell growth via the ROS-AKT/mTOR pathway. Biochemical Pharmacology. 194. 114795–114795. 5 indexed citations
10.
Gao, Shangfeng, Junbo Zhou, Cheng Li, et al.. (2021). BYSL contributes to tumor growth by cooperating with the mTORC2 complex in gliomas. Cancer Biology and Medicine. 18(1). 88–104. 22 indexed citations
11.
Zheng, Yang, Chao Wang, Yuemei Yang, et al.. (2021). Cytoplasmic eIF6 promotes OSCC malignant behavior through AKT pathway. Cell Communication and Signaling. 19(1). 121–121. 9 indexed citations
12.
Song, An, Yi Wang, Ming Wang, et al.. (2021). Semaphorin3A promotes osseointegration of titanium implants in osteoporotic rabbits. Clinical Oral Investigations. 26(1). 969–979. 4 indexed citations
13.
Song, An, Yuanyuan Wu, Xueming Yang, et al.. (2021). Involvement of miR-619-5p in resistance to cisplatin by regulating ATXN3 in oral squamous cell carcinoma. International Journal of Biological Sciences. 17(2). 430–447. 16 indexed citations
14.
Zeng, Da, et al.. (2020). Microarc oxidation surface of titanium implants promote osteogenic differentiation by activating ERK1/2-miR-1827-Osterix. In Vitro Cellular & Developmental Biology - Animal. 56(4). 296–306. 8 indexed citations
15.
Zheng, Yang, An Song, Chundi Wang, et al.. (2020). Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma. Cell Death and Disease. 11(8). 615–615. 4 indexed citations
16.
Zhou, Junbo, et al.. (2020). [Clinical evaluation of mandibular impacted third molar removed without surgical flaps].. PubMed. 29(2). 221–224. 1 indexed citations
17.
Zhou, Junbo, Tong Zhang, Cheng Li, et al.. (2020). BYSL Promotes Glioblastoma Cell Migration, Invasion, and Mesenchymal Transition Through the GSK-3β/β-Catenin Signaling Pathway. Frontiers in Oncology. 10. 565225–565225. 19 indexed citations
18.
Chen, Xianzhong, Junbo Zhou, Lihua Zhang, et al.. (2018). Development of an Escherichia coli-based biocatalytic system for the efficient synthesis of N-acetyl-D-neuraminic acid. Metabolic Engineering. 47. 374–382. 18 indexed citations
19.
20.
Weng, Qinjie, et al.. (2012). ANTI -INFLAMMATORY AND ANTI -NOCICEPTIVE ACTIVITIES OF THE EXTRACTS OF SARGENTODOXA CUNEATA AND ITS EFFECTS ON THE MODEL RATS WITH PELVIC INFLAMMATION. The Journal of Animal and Plant Sciences. 22(1). 44–50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qian Lin Breakdown of academic impact, for papers by Zhitong Deng Breakdown of academic impact, for papers by Nadia Ninfa Albanese Breakdown of academic impact, for papers by Xuan Xie Breakdown of academic impact, for papers by Su-Jae Lee Breakdown of academic impact, for papers by Reidun Aesöy Breakdown of academic impact, for papers by Joshua Brown-Clay Breakdown of academic impact, for papers by Kazuhisa Minamiguchi Breakdown of academic impact, for papers by Kenichi Iwai Breakdown of academic impact, for papers by Yuwei Zhang
Rankless by CCL
2026